These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12544665)

  • 1. Genetics and molecular biology.
    Recalde D; Zakin MM
    Curr Opin Lipidol; 2003 Feb; 14(1):99-101. PubMed ID: 12544665
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics and molecular biology: a role for adipocyte lipid-binding protein in atherosclerosis.
    Medh JD
    Curr Opin Lipidol; 2002 Feb; 13(1):93-5. PubMed ID: 11790967
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics and molecular biology.
    Garcia-Otin AL; Zakin MM
    Curr Opin Lipidol; 2003 Oct; 14(5):531-5. PubMed ID: 14501592
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid metabolism: inflammatory-immune responses in atherosclerosis.
    Davidson J; Rotondo D
    Curr Opin Lipidol; 2003 Jun; 14(3):337-9. PubMed ID: 12840665
    [No Abstract]   [Full Text] [Related]  

  • 5. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
    Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptors in atherosclerosis: new answers, new questions.
    Mazzone T
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2506-8. PubMed ID: 11116044
    [No Abstract]   [Full Text] [Related]  

  • 7. Are nuclear factors the ultimate targets of drugs affecting lipid metabolism?
    Fruchart JC
    Curr Atheroscler Rep; 2000 Sep; 2(5):353-4. PubMed ID: 11122765
    [No Abstract]   [Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors in atherosclerosis.
    Medh JD
    Curr Opin Lipidol; 1999 Feb; 10(1):69-71. PubMed ID: 10095993
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid metabolism.
    Rotondo D; Davidson J
    Curr Opin Lipidol; 1998 Oct; 9(5):503-5. PubMed ID: 9812206
    [No Abstract]   [Full Text] [Related]  

  • 10. [Regulation of lipid metabolism by liver X-activated receptors].
    Wu J; Zhang ZW; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):69-72. PubMed ID: 15127605
    [No Abstract]   [Full Text] [Related]  

  • 11. Bimonthly update: lipidology. Atherosclerosis: cell biology and lipoproteins.
    Ares MP
    Curr Opin Lipidol; 2000 Oct; 11(5):563-5. PubMed ID: 11048900
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid metabolism: peroxisome proliferator-activated receptor-alpha and atherosclerosis.
    van Greevenbroek MM; van der Kallen CJ
    Curr Opin Lipidol; 2002 Apr; 13(2):223-5. PubMed ID: 11891425
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics and molecular biology.
    Chan L; Ehnholm C
    Curr Opin Lipidol; 1997 Apr; 8(2):57-9. PubMed ID: 9183541
    [No Abstract]   [Full Text] [Related]  

  • 14. [The anti-atherogenic role of peroxisome proliferator activated receptors (PPARs)].
    Skoczyńska A; Poreba R; Sieradzki A; Turczyn B
    Pol Arch Med Wewn; 2002 Nov; 108(5):1125-31. PubMed ID: 12685256
    [No Abstract]   [Full Text] [Related]  

  • 15. Bibliography. Current world literature. Genetics and Molecular Biology.
    Curr Opin Lipidol; 2005 Apr; 16(2):215-41. PubMed ID: 15767862
    [No Abstract]   [Full Text] [Related]  

  • 16. Atherosclerosis: cell biology and lipoproteins.
    Ares MP
    Curr Opin Lipidol; 2002 Feb; 13(1):105-7. PubMed ID: 11790970
    [No Abstract]   [Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma and atherosclerosis.
    Marx N
    Curr Hypertens Rep; 2002 Feb; 4(1):71-7. PubMed ID: 11790295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis.
    Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
    Trends Pharmacol Sci; 2003 Oct; 24(10):530-4. PubMed ID: 14559405
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in the study of PPARs].
    Yang GR; Zhang ZW; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):329-32. PubMed ID: 14992015
    [No Abstract]   [Full Text] [Related]  

  • 20. PPARgamma and metabolism: insights from the study of human genetic variants.
    Gurnell M
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):267-77. PubMed ID: 12919147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.